Powered by
Therachon Announces Presentation at the 2nd Fibroblast Growth Factors in Development and Repair Conference

Therachon AG , a biotechnology company focused on rare genetic diseases, announced today that Jeffrey Stavenhagen, Ph.D., Vice President Biology, will be presenting at the 2nd Fibroblast Growth Factors in Development and Repair Conference in Cancun, Mexico.

Dr. Stavenhagen will present, "Development of a Novel Biologic for the Treatment of Achondroplasia" on Wednesday, March 8th from 6:35 - 6:55 PM ET. The presentation will take place at the Fiesta Americana Condesa hotel. For more informa

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox
Related News Feeds

Mentioned Entities

See how you can reach these people and organizations